Medios
Drug Stores & Pharmacies · Germany · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Heidestraße 9, Berlin, Berlin, 10557, Ge...Phone Number
+49 30232566800Website
www.medios.agRevenue
$1.9 BillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Medios
Medios AG is a leader in Specialty Pharma, dedicated to providing innovative medication therapies across Europe where they are needed. The company focuses on patient-specific therapies for pharmacies, doctors, pharmaceutical companies, and study operators. Additionally, Medios is committed to advancing biotechnology and precision medicine through its Advanced Therapies initiatives. Their mission emphasizes the importance of individual medicine for the future.Explore more
Medios Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medios your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medios launches new products
Click to see if Medios had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Medios has new funding data
Check out if Medios is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Medios
Check if Medios has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Medios recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Medios, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Medios as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Medios is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Medios is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Medios.
Medios Tech Stack
A closer look at the technologies used by Medios
See more technologies
Most Recent Scoops
Hiring Plans
Medios has more open roles in IT Asset Management than it has had at any time in the past 12 months.
Open Position
Open Position
Lateral Move
Executive Move
Board of Directors
Medios News & Media
Private companies account for 35% of Medios AG's (ETR:ILM1) ownership, while institutions account for 26%
Key Insights Significant control over Medios by private companies implies that the general public has more power to...Is Now The Time To Put Medios (ETR:ILM1) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Medios AG (MEDOF) Q3 2025 Earnings Call Prepared Remarks Transcript
Medios AG (OTCPK:MEDOF) Q3 2025 Earnings Call November 10, 2025 7:00 PM ESTCompany ParticipantsClaudia Nickolaus - Head of Investor, Public Relations, ESG...Institutions own 31% of Medios AG (ETR:ILM1) shares but private companies control 35% of the company
XTRA:ILM1 1 Year Share Price vs Fair Value Explore Medios's Fair Values from the Community and select yours Key...
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medios
Sign Up For FreeTo access detailed company insights
Medios AG is a leader in Specialty Pharma, dedicated to providing innovative medication therapies across Europe where they are needed. The company focuses on patient-specific therapies for pharmacies, doctors, pharmaceutical companies, and study operators. Additionally, Medios is committed to advancing biotechnology and precision medicine through i... Read More
